Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zaltrap in Recurrent Inoperable Stage III or IV Melanoma
NCT00450255Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2007
- Primary completion
- Jan 2011
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in melanoma, sponsored by National Cancer Institute. Started Jun 2007; status: completed.
02
Drugs
aflibercept
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00450255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450255.